参考文献/References:
[1]秦泽莲,刘刚,聂兴举,等. “瘢痕疙瘩和增生性瘢痕组织差异表达基因文库及其构建方法”国家发明专利,专利号03136990.1,2007年6月27日授权公告.
[2]Low TL, Hu SK, Goldstein AL. Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proc Natl Acad Sci U S A, 1981, 78(2):1162-1166.
[3]Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol, 1999, 113(3):364-368.
[4]Goldstein AL,Hannappel E,Kleinman HK.Thymosin β4:actinsequestering protein moonlights to repair injured tissues. Trends Mol Med,2005, 11(9):421-429.
[5]Yamamoto T,Gotoh M,Kitajima M,et al.Thymosin beta4 expression is correlated with metastatic capacity of colorectal carcinomas. Biochem Biophys Res Commun, 1993, 193(2):706-710.
[6]Vigneswaran N, Wu J, Sacks P, et al. Microarray gene expression profiling of cell lines from primary and metastatic tongue squamous cell carcinoma; possible insights from emerging technology. J Oral Pathol Med, 2005, 34(2):77-86.
[7]Condon MR, Hall AK. Expression of thymosin beta-4 and related genes in developing human brain. J Mol Neurosci, 1992, 3(3):165-170.
[8]Low TL,Goldstein AL.Thymosins:structure,function and therapeutic applications. Thymus,1984, 6(1-2):27-42.
[9]聂芳菲,吴江群,秦泽莲. 瘢痕疙瘩和增生性瘢痕中胸腺素β4基因表达变化及其意义.中国危重病急救医学,2005, 17(2): 80-83.
[10]Smart N,Risebro CA,Melville AA,et al. Thymosinβ4 is essential for coronary vessel development and promotes neovascularisation via adult epicardium.Ann N Y Acad Sci, 2007, 1112:171-188.
[11]Goodall GL, Morgan JI, Horecker BL. Thymosin beta 4 in cultured mammalian cell lines. Arch Biochem Biophys, 1983, 221(2):598-601.
[12]Malinda KM, Goldstein AL, Kleinman HK. Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J, 1997, 11(6):474-481.
[13]Yu FX, Lin SC, MorrisonBogorad M, et al. Thymosin beta 10 and thymosin beta 4 are both actin monomer sequestering proteins. J Biol Chem, 1993, 268(1):502-509.
[14]左伋, 主编.医学分子细胞生物学.第1版.上海:复旦大学出版社,2005.36-41.
[15]Lawrence WT, Diegelmann RF. Growth factors in wound healing. Clin Dermatol, 1994, 12: 157-169.
[16]Weller FE, Mutchnick MG, Goldstein AL, et al. Enzyme immunoassay measurement of thymosin β4 in human serum. J Biol Resp Mod, 1988, 7:91-96.
[17]Desmouliere A, Badid C, BochatonPiallat ML. Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int J Biochem Cell Biol, 1997, 29: 19-30.
[18]Appleton I,Brown NJ.Apoptosis,necrosis,and proliferation:possible implications in the etiology of keloids. Am J Pathol, 1996, 149(5):1441-1447.
[19]Varedi M, Tredget EE, Scott PG, et al. Alteration in cell morphology triggers transforming growth factorβ1, collagenase, and tissue inhibitor of metalloproteinasesⅠexpression in normal and hypertrophic scar fibroblasts. J Invest Dermatol, 1995, 104(1):118-123.